Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2

Renal cell carcinoma (RCC) is one of the most common malignant tumors affecting the urogenital system, accounting for 90% of renal malignancies. Traditional chemotherapy options are often the front-line choice of regimen in the treatment of patients with RCC, but responses may be modest or limited d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lu, Chen, Le, Qin, Zhiyuan, Lei, Jinxiu, Ye, Sheng, Zeng, Kui, Wang, Hua, Ying, Meidan, Gao, Jianqing, Zeng, Su, Yu, Lushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804444/
https://www.ncbi.nlm.nih.gov/pubmed/31649850
http://dx.doi.org/10.1016/j.apsb.2019.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804444/
https://www.ncbi.nlm.nih.gov/pubmed/31649850
http://dx.doi.org/10.1016/j.apsb.2019.01.002

Ejemplares similares